Search Results

There are 1883428 results for: content related to: BRAF V600E mutations in bile duct adenomas

  1. BRAF V600E mutational status in bile duct adenomas and hamartomas


    Volume 67, Issue 4, October 2015, Pages: 562–567, Anaïs Pujals, Paulette Bioulac-Sage, Claire Castain, Cécile Charpy, Elie Serge Zafrani and Julien Calderaro

    Version of Record online : 31 MAR 2015, DOI: 10.1111/his.12674

  2. BRAF V600E mutation in biliary proliferations associated with α1-antitrypsin deficiency


    Volume 70, Issue 3, February 2017, Pages: 485–491, Napat Angkathunyakul, Francesca Rosini, Nigel Heaton, Pierre Foskett and Alberto Quaglia

    Version of Record online : 15 NOV 2016, DOI: 10.1111/his.13083

  3. BRAF-Mutated Pleomorphic Xanthoastrocytoma is Associated with Temporal Location, Reticulin Fiber Deposition and CD34 Expression

    Brain Pathology

    Volume 24, Issue 3, April 2014, Pages: 221–229, Christian Koelsche, Felix Sahm, Adelheid Wöhrer, Astrid Jeibmann, Jens Schittenhelm, Patricia Kohlhof, Matthias Preusser, Bernd Romeike, Hildegard Dohmen-Scheufler, Christian Hartmann, Michel Mittelbronn, Albert Becker, Andreas von Deimling and David Capper

    Version of Record online : 29 JAN 2014, DOI: 10.1111/bpa.12111

  4. Concordance in BRAF V600E status over time in malignant melanoma and corresponding metastases


    Accepted manuscript online: 8 NOV 2017, Line Bjerrehave Nielsen, Nina Dabrosin, Karen Sloth, Marie Louise Bønnelykke–Behrndtz, Torben Steiniche and Johanne Lade-Keller

    DOI: 10.1111/his.13431

  5. You have free access to this content
    Comparative analysis of BRAF,NRAS and c-KIT mutation status between tumor tissues and autologous tumor cell-lines of stage III/IV melanoma

    Experimental Dermatology

    Volume 24, Issue 1, January 2015, Pages: 70–73, Anne-Chantal Knol, Marie-Christine Pandolfino, Audrey Vallée, Frédérique Nguyen, Virginie Lella, Amir Khammari, Marc Denis, Anne-Laure Puaux and Brigitte Dréno

    Version of Record online : 8 DEC 2014, DOI: 10.1111/exd.12584

  6. You have free access to this content
    Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules


    Volume 119, Issue 8, 15 April 2013, Pages: 1495–1502, David A. Kleiman, Matthew J. Sporn, Toni Beninato, Michael J. Crowley, Anvy Nguyen, Alessia Uccelli, Theresa Scognamiglio, Rasa Zarnegar and Thomas J. Fahey III

    Version of Record online : 21 DEC 2012, DOI: 10.1002/cncr.27888

  7. Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up

    Brain Pathology

    Volume 25, Issue 5, September 2015, Pages: 575–586, Cristiane M. Ida, Fausto J. Rodriguez, Peter C. Burger, Alissa A. Caron, Sarah M. Jenkins, Grant M. Spears, Dawn L. Aranguren, Daniel H. Lachance and Caterina Giannini

    Version of Record online : 5 DEC 2014, DOI: 10.1111/bpa.12217

  8. Validation of the VE1 immunostain for the BRAFV600E mutation in melanoma

    Journal of Cutaneous Pathology

    Volume 41, Issue 9, September 2014, Pages: 724–732, Michelle V. Pearlstein, Daniel C. Zedek, David W. Ollila, Amanda Treece, Margaret L. Gulley, Pamela A. Groben and Nancy E. Thomas

    Version of Record online : 4 JUL 2014, DOI: 10.1111/cup.12364

  9. Papillary thyroid carcinomas with and without BRAF  V600E mutations are morphologically distinct


    Volume 60, Issue 7, June 2012, Pages: 1052–1059, Alexander Finkelstein, Gillian H Levy, Pei Hui, Avinash Prasad, Renu Virk, David C Chhieng, Tobias Carling, Sanziana A Roman, Julie A Sosa, Robert Udelsman, Constantine G Theoharis and Manju L Prasad

    Version of Record online : 15 FEB 2012, DOI: 10.1111/j.1365-2559.2011.04149.x

  10. Melanocytic naevi with globular and reticular dermoscopic patterns display distinct BRAF V600E expression profiles and histopathological patterns

    British Journal of Dermatology

    Volume 171, Issue 5, November 2014, Pages: 1060–1065, M.A. Marchetti, M.H. Kiuru, K.J. Busam, A.A. Marghoob, A. Scope, S.W. Dusza, M.A. Cordova, M. Fonseca, X. Wu and A.C. Halpern

    Version of Record online : 20 OCT 2014, DOI: 10.1111/bjd.13260

  11. You have full text access to this OnlineOpen article
    Prevalence and clinical significance of BRAF V600E in Chinese patients with lung adenocarcinoma

    Thoracic Cancer

    Volume 6, Issue 3, May 2015, Pages: 269–274, Zhenxiang Li, Leilei Jiang, Hua Bai, Zhijie Wang, Jun Zhao, Jianchun Duan, Xiaodan Yang, Tongtong An and Jie Wang

    Version of Record online : 24 APR 2015, DOI: 10.1111/1759-7714.12177

  12. Mutational status of naevus-associated melanomas

    British Journal of Dermatology

    Volume 173, Issue 3, September 2015, Pages: 671–680, D. Shitara, G. Tell-Martí, C. Badenas, M.M.S.S. Enokihara, L. Alós, A.B. Larque, N. Michalany, J.A. Puig-Butille, C. Carrera, J. Malvehy, S. Puig and E. Bagatin

    Version of Record online : 19 JUN 2015, DOI: 10.1111/bjd.13829

  13. You have free access to this content
    Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma

    International Journal of Cancer

    Volume 137, Issue 5, 1 September 2015, Pages: 1001–1011, Greta Gandolfi, Valentina Sancisi, Simonetta Piana and Alessia Ciarrocchi

    Version of Record online : 27 MAY 2014, DOI: 10.1002/ijc.28976

  14. Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis

    Genes, Chromosomes and Cancer

    Volume 52, Issue 1, January 2013, Pages: 99–106, Rina Kansal, Leticia Quintanilla-Martinez, Vivekananda Datta, Jean Lopategui, Gary Garshfield and Bharat N. Nathwani

    Version of Record online : 21 SEP 2012, DOI: 10.1002/gcc.22010

  15. BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas

    Head & Neck

    Volume 35, Issue 4, April 2013, Pages: 548–553, Ji In Lee, Hye Won Jang, Sun Wook Kim, Jong–Won Kim, Young Lyun Oh and Jae Hoon Chung

    Version of Record online : 7 APR 2012, DOI: 10.1002/hed.22997

  16. BRAF V600E Mutation Is Associated with mTOR Signaling Activation in Glioneuronal Tumors

    Brain Pathology

    Volume 24, Issue 1, January 2014, Pages: 52–66, Avanita S. Prabowo, Anand M. Iyer, Tim J. Veersema, Jasper J. Anink, Antoinette Y. N. Schouten-van Meeteren, Wim G. M. Spliet, Pieter C. van Rijen, Cyrille H. Ferrier, David Capper, Maria Thom and Eleonora Aronica

    Version of Record online : 11 SEP 2013, DOI: 10.1111/bpa.12081

  17. Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype

    International Journal of Laboratory Hematology

    Volume 34, Issue 4, August 2012, Pages: 417–421, S. E. LANGABEER, D. O’BRIEN, S. LIPTROT, C. M. FLYNN, P. J. HAYDEN, E. CONNEALLY, P. V. BROWNE and E. VANDENBERGHE

    Version of Record online : 7 FEB 2012, DOI: 10.1111/j.1751-553X.2012.01402.x

  18. Initial clinical experience with BRAFV600E mutation analysis of core-needle biopsy specimens from thyroid nodules

    Clinical Endocrinology

    Volume 84, Issue 4, April 2016, Pages: 607–613, Sang Hyun Choi, Jung Hwan Baek, Jeong Hyun Lee, Young Jun Choi, Eun Ju Ha, Dong Eun Song, Jae Kyun Kim, Ki-Wook Chung, Tae Yong Kim, Won Bae Kim and Young Kee Shong

    Version of Record online : 27 AUG 2015, DOI: 10.1111/cen.12866

  19. Absence of BRAF V600E in non-infiltrative, non-invasive follicular variant of papillary thyroid carcinoma


    Volume 67, Issue 4, October 2015, Pages: 579–582, Brooke E Howitt, Vera A Paulson and Justine A Barletta

    Version of Record online : 9 APR 2015, DOI: 10.1111/his.12680

  20. Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 1, February 2015, Pages: 121–123, S. Parakh, C. Murphy, D. Lau, J. S. Cebon and M. C. Andrews

    Version of Record online : 10 NOV 2014, DOI: 10.1111/jcpt.12229